Discover BMB 2024 symposia: What are they really all about?
Back in June, the organizers of Discover BMB 2024 announced the titles and organizers of the thematic symposia for the American Society for Biochemistry and Molecular Biology’s annual meeting, scheduled to take place March 23–26 at the Henry B. Gonzalez Convention Center, in San Antonio.
But you want to know more than the names of these sessions. Click on the links below to read what each symposium’s organizers have to say about their sessions, including who will be speaking, who should attend, — even their theme song.
Dive deeper into what #DiscoverBMB programming will be all about.
Biochemistry of the multitudes
Microbial signaling, communication and metabolism
Peter Chien, University of Massachusetts, Amherst; Jade Wang, University of Wisconsin, Madison
Enzymes: Still cool after all these years
Cool and novel enzymes
Shelley Copley, University of Colorado, Boulder; Hung-wen (Ben) Liu, The University of Texas at Austin
Processing and translating RNA in health and disease
RNA biology
Katrin Karbstein, University of Florida, Scripps Biomedical Research; Jeremy Wilusz, Baylor College of Medicine
Our coolest superpower: Seeing all the atoms
New frontiers in structural biology
Jose Rodriguez, University of California, Los Angeles; Hosea Nelson, California Institute of Technology
Building natural products
Advances in natural product biochemistry and biotechnology
Yi Tang, University of California, Los Angeles; Katherine Ryan, University of British Columbia
Dancing with metals: Iron, copper and reactive sparks
Redox and metals in biology
Siavash Kurdistani, University of California, Los Angeles; Gina DeNicola, Moffitt Cancer Center
MCSs stick the landing
Membrane contact sites
Chris Beh, Simon Fraser University; Jen Liou, University of Texas Southwestern Medical Center
Lipids hold it all together
Lipid metabolism
Maria Fedorova, Dresden University of Technology; Neale Ridgway, Dalhousie University
Out with the old, in with the nucleus
Signaling mechanisms in the nucleus
Glen Liszczak, University of Texas Southwestern Medical Center; Aaron Johnson, University of Colorado Anschutz Medical Campus
The specialized metabolism and trafficking of cellular subcompartments
Mitochondria, peroxisomes and chloroplast metabolism
Pere Puigserver, Harvard Medical School; Greg Moorhead, University of Calgary
Biochemists face the climate challenge
Maximizing Access Committee
Kayunta Johnson–Winters, University of Texas–Arlington; Karla Neugebauer, Yale School of Medicine
Stressed out? The cancer playbook may help
Maximizing Access Committee
Jonathan Kelber, Baylor University
Teaching and engaging Gen Z: Two sides of the same coin
Education and professional development
Saumya Ramanathan, Arizona State University
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.
Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.
Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.
The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.
Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.
Catching tau in the act
Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.